Co-Authors
This is a "connection" page, showing publications co-authored by ANTHONY LUCCI and CAROLYN S HALL.
Connection Strength
3.321
-
Circulating Tumor Cells in Breast Cancer Patients. Crit Rev Oncog. 2016; 21(1-2):125-39.
Score: 0.541
-
Circulating Tumor Cells After Neoadjuvant Chemotherapy in Stage I-III Triple-Negative Breast Cancer. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S552-8.
Score: 0.518
-
Disseminated tumor cells predict survival after neoadjuvant therapy in primary breast cancer. Cancer. 2012 Jan 15; 118(2):342-8.
Score: 0.396
-
How heterogeneous cell populations, cancer cell dormancy, and minimal residual disease influence the natural history of cancers. Oncology (Williston Park). 2011 Jan; 25(1):47, 50.
Score: 0.383
-
Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients. Ann Surg Oncol. 2010 Dec; 17(12):3252-8.
Score: 0.369
-
The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer. Ann Surg Oncol. 2021 Aug; 28(8):4265-4274.
Score: 0.192
-
Circulating Tumor Cells in Breast Cancer. Recent Results Cancer Res. 2020; 215:127-145.
Score: 0.179
-
Circulating tumor cells in non-metastatic triple-negative breast cancer. Breast Cancer Res Treat. 2014 Sep; 147(2):325-33.
Score: 0.123
-
Cyclooxygenase-2 expression in non-metastatic triple-negative breast cancer patients. Mol Clin Oncol. 2014 Sep; 2(5):845-850.
Score: 0.122
-
Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer. Cancer Med. 2013 Apr; 2(2):226-33.
Score: 0.111
-
Detection of minimal residual disease in blood and bone marrow in early stage breast cancer. Cancer. 2010 Jul 15; 116(14):3330-7.
Score: 0.093
-
Role of COX-2 in tumorospheres derived from a breast cancer cell line. J Surg Res. 2011 Jun 01; 168(1):e39-49.
Score: 0.091
-
Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cells. J Surg Res. 2008 Jun 15; 147(2):240-6.
Score: 0.079
-
Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol. 2021 Aug; 28(8):4615-4622.
Score: 0.048
-
Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma. Cancers (Basel). 2019 Jun 20; 11(6).
Score: 0.043
-
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer. Clin Cancer Res. 2016 05 15; 22(10):2583-93.
Score: 0.034